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ABSTRACT
Aim The aim of this systematic review was to assess 
the effectiveness of rehabilitation interventions on the 
secondary physical, neurological and psychological 
consequences of cardiac arrest (CA) for adult survivors.
Methods A literature search of electronic databases 
(MEDLINE, Allied and Complementary Medicine Database, 
Cumulative Index to Nursing and Allied Health Literature, 
Excerpta Medica database, Psychological Information 
Database, Web of Science and Cochrane Central Register 
of Controlled trials) was conducted for randomised 
controlled trials (RCTs) and observational studies up to 
18 April 2021. The primary outcome was health- related 
quality of life (HRQoL) and main secondary outcome was 
neurological function with additional secondary outcomes 
being survival, rehospitalisation, safety (serious and non- 
serious adverse events), psychological well- being, fatigue, 
exercise capacity and physical capacity. Two authors 
independently screened studies for eligibility, extracted 
data and assessed risk of bias.
Results Three RCTs and 11 observational studies were 
included (total 721 participants). Study duration ranged 
from 8 weeks to 2 years. Pooled data from two RCTs 
showed low- quality evidence for no effect on physical 
HRQoL (standardised mean difference (SMD) 0.19, (95% 
CI: −0.09 to 0.47)) and no effect on mental HRQoL (SMD 
0.27 (95% CI: −0.01 to 0.55)).
Regarding secondary outcomes, very low- quality 
evidence was found for improvement in neurological 
function associated with inpatient rehabilitation for CA 
survivors with acquired brain injury (SMD 0.71, (95% CI: 
0.45 to 0.96)) from five observational studies. Two small 
observational studies found exercise- based rehabilitation 
interventions to be safe for CA survivors, reporting no 
serious or non- serious events.
Conclusions Given the overall low quality of evidence, this 
review cannot determine the effectiveness of rehabilitation 
interventions for CA survivors on HRQoL, neurological 
function or other included outcomes, and recommend 
further high- quality studies be conducted. In the interim, 
existing clinical guidelines on rehabilitation provision 
after CA should be followed to meet the high burden of 
secondary consequences suffered by CA survivors.
PROSPERO registration number CRD42018110129.
INTRODUCTION
The number of people surviving a cardiac 
arrest (CA) to hospital discharge is increasing 
due to improvements in postcardiac arrest 
systems of care.1 In the USA, survival to 
hospital discharge is now 11.4% translating 
to 70 000 new CA survivors each year with this 
number expected to increase.1 2 However, 
after survival, multiple research studies have 
documented the secondary physical, neuro-
logical and psychological consequences for 
CA survivors.1 3–6 Rehabilitation helps people 
to achieve and maintain optimum functioning 
in interaction with their environments.7 
Rehabilitation interventions have shown 
benefits for the secondary consequences of 
brain injury or cardiac events8 9 indicating the 
same may be true for CA survivors. Rehabilita-
tion after surviving a CA is recommended in 
consensus- based international clinical guide-
lines1 10 11 but, to date, there has not been a 
Strengths and limitations of this study
 ► This is the first systematic review and meta- analysis 
to assess the effectiveness of rehabilitation inter-
ventions for cardiac arrest (CA) survivors.
 ► Comprehensive literature searches were conducted 
with the inclusion of both randomised controlled trial 
and observational studies, and a wide range of out-
comes relevant to CA survivors.
 ► High heterogeneity in intervention design and out-
come measures limited the possibility for meta- 
analysis of study results.
 ► Quality of evidence was generally low with the ma-
jority of studies having small or very small sample 
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systematic assessment of the effectiveness of rehabilitation 
interventions for CA survivors.12 In previous consensus 
building research with survivors, relatives and clinicians, 
quality of life and neurological function were identified 
as important outcomes after CA.4 13
The aim of this systematic review and meta- analysis was 
to assess the effectiveness of rehabilitation interventions 
for adult CA survivors. The primary outcome was health- 
related quality of life (HRQoL) and main secondary 
outcome was neurological function. Additional secondary 
outcomes were survival, rehospitalisation, safety (serious 
and non- serious adverse events), psychological well- being, 
fatigue, exercise capacity and physical capacity.
METHODS
Protocol and registration
This systematic review and meta- analysis is reported 
according to the Preferred Reporting Items for System-
atic Reviews and Meta- Analyses guidelines (online supple-
mental file 1).14
Eligibility criteria
Studies using randomised controlled trials (RCTs) using 
individual or cluster randomisation in a parallel or cross- 
over design, pilot studies, non- RCTs and prospective/
retrospective observational studies were included. Studies 
using a case series or case report design were excluded.
The parameters for the systematic review were defined 
using the Population, Intervention Comparator, Outcome 
(PICO) framework. The question being: What is the 
effectiveness among adult (≥18 years) CA survivors (P), 
of rehabilitation interventions (I) on HRQoL and neuro-
logical function (O)? Comparator was defined as no treat-
ment, active control, usual care, additional intervention 
or no comparator (C). No restriction on publication date, 
language or length of follow- up was made.
Studies that included both CA survivors and people 
with cardiac disease without CA were eligible for inclu-
sion if subgroup data for CA survivors were presented or 
if these specific data could be obtained by contacting the 
study authors. If separate subgroup data for CA survivors 
could not be acquired, studies were eligible for inclusion 
if at least 50% of participants were CA survivors. Studies 
with mixed CA survivors and non- CA survivors acquired 
brain injury populations were treated in the same way.
Rehabilitation can be defined as: ‘A set of measures that 
assist individuals, who experience or are likely to experi-
ence disability, to achieve and maintain optimum func-
tioning in interaction with their environments’.7 To align 
with this broad definition of rehabilitation and ensure 
inclusion of all possible rehabilitation interventions, 
interventions were included if they were not primarily 
pharmacologically or surgically based or involved invasive 
technology. Interventions in the emergency room or crit-
ical care unit setting were excluded.
The primary outcome was HRQoL. HRQoL outcome 
measures could include generic or disease- specific 
patient- reported outcome measures and could be either 
a single item or multi- item outcome measure. The main 
secondary outcome was neurological function, defined 
as measuring the level of disability after a neurological 
event. Measures may primarily test cognitive ability or may 
combine cognitive and physical ability hence measuring 
global disability. Additional secondary outcomes were 
survival, rehospitalisation, safety (serious and non- serious 
adverse events), psychological well- being, fatigue, exer-
cise capacity and physical capacity. Measures may be 
patient reported, clinician reported, observer reported 
or performance based. The primary and main secondary 
outcomes were chosen as, alongside survival, HRQoL and 
neurological function have been identified as important 
core outcome domains after CA by survivors, relatives and 
clinicians.4 13 Choice of secondary outcomes was informed 
by existing evidence on the secondary consequences of 
CA1 3 5 6 and inspired by outcomes in previous systematic 
reviews on rehabilitation with other cardiac disease popu-
lations.8 15
Information sources
Preliminary searches were conducted to identify relevant 
search terms and subject headings. The final systematic 
search for eligible studies was conducted in the online 
databases: The National Library of Medicine (MEDLINE), 
Allied and Complementary Medicine Database, Cumu-
lative Index to Nursing and Allied Health Literature, 
Excerpta Medica database, Psychological Information 
Database, Web of Science, Cochrane Database of System-
atic Reviews and Cochrane Central Register of Controlled 
trials were initially searched on 2 December 2019 and 
updated on 18 April 2021. Abstracts from the ‘postcar-
diac arrest conferences’ 2013–2019 were hand searched, 
and bibliographies of articles included at the full- text 
stage were reviewed to identify possible additional 
studies. Ongoing trials were identified by searching clin-
ical trial registries (International Standard Randomised 
Controlled Trial Number, WHO International Clinical 
Trials Registry Platform and  ClinicalTrials. gov).
Searches
The search matrix consisted of a combination of keywords 
and synonyms for: (1) CA and (2) non- pharmacological/
surgical/invasive technology rehabilitation interventions. 
The complete search strategy and detailed search matrix 
is outlined in online supplemental table 1.
Study selection
Using the technology platform Covidence, two authors 
(VLJ and EL) independently screened all identified 
studies, first by title and abstract, and then after reading 
the full- text articles. First and last authors of studies were 
contacted where full- text articles were unavailable or CA 
survivors subgroup data were required. Any disagree-
ments in the screening process were discussed between 













pen: first published as 10.1136/bm






3Joshi VL, et al. BMJ Open 2021;11:e047251. doi:10.1136/bmjopen-2020-047251
Open access
Data collection process
Data were extracted from the included studies inde-
pendently by two review authors (VLJ and LHT) using a 
predefined standardised data extraction form. Any incon-
sistencies between authors in the data extraction process 
were resolved by discussion and if necessary a third author 
was consulted (JC).
Data items
Extracted data items included: study characteristics 
(author, year of publication, country, number of groups, 
number of participants, inclusion and exclusion criteria, 
setting, method of recruitment, aim of study, study design, 
length of study), characteristics of participants (mean 
age, gender, ethnicity, cause of CA, and comorbidities), 
description of intervention (duration, timing after CA, 
provider of intervention, description of control if rele-
vant), theory or mechanism of intervention, outcomes 
(measured at baseline, hospital discharge, 3 months and 
final follow- up point and, if present, mortality, rehospi-
talisation, serious and non- serious adverse events) and 
results (sample sizes, baseline and all follow- up points, 
mean, estimate of effect, CI, SD, p value).
Risk of bias in individual studies
Two researchers independently assessed risk of bias for 
the included studies. RCTs were assessed using the RoB 
2: a revised tool for assessing risk of bias in randomised 
trials,16 and observational studies were assessed using the 
National Institutes of Health Quality Assessment Tool for 
Before- After (Pre- Post) Studies With No Control Group.17
Summary measures
For continuous data, the effectiveness of the rehabilita-
tion interventions was expressed either as mean differ-
ence (MD) or as standardised MD (SMD) with 95% CI. 
For time- to- event outcomes (survival, rehospitalisation), 
hazard ratios were pooled if presented.
Synthesis of results
If more than one study reported an outcome related 
to the outcomes of interest, the clinical heterogeneity 
(similarity in CA survivors population, rehabilitation 
interventions and outcomes) was assessed. If studies 
were considered clinically comparable, data were pooled 
using a random effects meta- analysis. SMD was calculated 
where the same outcome was reported but using different 
measurement tools with values of 0.2, 0.5 and 0.8 inter-
preted as small, medium and large effect sizes, respec-
tively. Separate analyses were conducted for RCTs and 
observational studies. Study heterogeneity was examined 
using the Cochran Q test and quantified with I2 statistic 
(statistical heterogeneity indicated by χ2 test, p<0.10 and 
an I2 statistic >50%). All analyses were conducted using 
STATA V.16 (StataCrop) statistical software.
Results from the Short Form Health Survey (SF-36 or 
SF-12) can be reported as either two component scores, 
(physical/mental) or as eight subscales. To allow synthesis 
of results, where results were reported as the eight 
subscales they were transformed into the two component 
scores following the method used by Matcham et al.18
Risk of bias and quality of evidence across studies
Grades of Recommendation, Assessment, Development 
and Evaluation system (GRADE)19 was used to assess the 
overall quality of evidence across studies separately for 
the primary and main secondary study outcomes.
Additional analyses
If possible, subgroup and stratified analyses, meta- 
regression and assessment of small study bias will be 
investigated as prespecified in the protocol (online 
supplemental file 1).
Patient and public involvement
The need for the systematic review of rehabilitation inter-
ventions, and identification of important outcomes for 
the systematic review, were developed from a patient and 




The search identified 6715 unique articles. After 
screening titles and abstracts, 43 full- text articles were 
screened, of which 14 studies were included for anal-
ysis.20–34 Studies excluded at the full- text stage are listed 
with reasons in online supplemental table 2. Figure 1 
presents the study flow chart and reasons for exclusion in 
the full text screening. Two registered ongoing trials were 
identified.35 36
Study characteristics
Study characteristics of the 14 included studies are 
described in online supplemental table 1.
Three RCTs (total 393 participants) and 11 observational 
studies (total 328 participants) were included. Nine studies 
Figure 1 Preferred Reporting Items for Systematic Reviews 
and Meta- analyses flow diagram describing study selection.
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investigated outpatient or community- based rehabilitation 
interventions of which three were RCTs. Five studies investi-
gated inpatient rehabilitation for acquired brain injury, all 
were observational studies. Considering the very different 
CA survivor populations and intervention settings, the 
results for outpatient or community- based rehabilitation 
studies and inpatient rehabilitation for acquired brain 
injury are presented separately. Study follow- up period 
ranged from 1 to 24 months. One study25 had CA survivors 
in both arms of the RCT receiving the same intervention, 
hence, data from both arms were combined and treated as 
one observational study (data obtained from study authors).
Risk of bias within studies
Risk of bias assessments are summarised in figure 2A,B. 
Of the three included RCTs,21–23 31 Moulaert et al31 was 
assessed as having ‘some concerns’ and the two other 
studies21–23 were assessed having a ‘high risk’ of bias in the 
overall risk of bias assessment. Ten of the 11 observational 
studies had multiple high risk of bias domains.
Results of individual studies
A summary of the results of the individual studies is 
reported in online supplemental table 1.
Synthesis of results
Health-related quality of life
In total, two RCTs22 23 31 and four observational 
studies24 25 30 34 measured HRQoL.
HRQoL meta-analysis
Two RCTs22 23 31 evaluated the effectiveness of a rehabil-
itation intervention compared with standard care. The 
Figure 2 Quality assessment and risk of bias, review authors judgements about quality assessment and risk of bias for each 
included study. (A) Summary based on ‘RoB 2: a revised tool for assessing risk of bias in randomised trials’. (B) Summary based 
on ‘Quality Assessment Tool for Before- After (Pre- Post) Studies With No Control Group’.  on S
eptem
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random effects meta- analyses showed from baseline to 
12 months follow- up, no statistically significant effective-
ness of rehabilitation interventions in physical HRQoL, 
overall SMD 0.19, (95% CI: −0.09 to 0.47, p=0.19), 
I2=00.0% or mental HRQoL, overall SMD 0.27, (95% CI: 
−0.01 to 0.55, p=0.06), I2=0.00% (figure 3A,B).
Two observational studies25 30 could be pooled and 
a significant improvement in physical HRQoL was 
observed 6 months after baseline assessment, overall SMD 
0.95, (95% CI: 0.64 to 1.27, p<0.001), I2=0.00%, p<0.001 
(figure 4A), however, no improvement in mental HRQoL 
was observed with an overall SMD 0.80, (95% CI: −0.45 to 
2.05, p=0.21), I2=90.17% (figure 4B).
HRQoL studies not included in meta-analysis
Due to clinical heterogeneity, two observational 
studies24 34 reporting on HRQoL were not included in 
the meta- analysis. One study,24 involving exercise- based 
rehabilitation, showed a non- significant increase in 
physical HRQoL at 8 weeks follow- up (44.33 points (SD 
10.77) to 47.19 (SD 9.11), p=0.19) and mental HRQoL 
(51.33 (SD 11.68) to 55.03 (SD 8.04), p=0.48). A second 
observational study34 involving a community- based reha-
bilitation intervention for CA survivors with acquired 
brain injury showed a significant increase in HRQoL at 
2 months follow- up (Quality of Life after Traumatic Brain 
Injury Satisfaction scale mean score, 82.25–89.95 points, 
p=0.015).
Neurological function
Neurological function was used as an outcome in one 
RCT31 and six observational studies.20 26 27 32–34
The RCT31 showed an outpatient rehabilitation inter-
vention had no significant effectiveness in improving 
cognitive function on performance- based cognitive tests 
compared with standard care at any follow- up point.
Neurological function meta-analysis
Five observational studies20 26 27 32 33 were included in a 
meta- analysis. This showed rehabilitation significantly 
increased clinician- reported function, overall SMD 0.71, 
(95% CI: 0.45 to 0.96, p<0.001), I2=17.36%, between 
admission and discharge for CA survivors with acquired 
brain injury (figure 5). Howell et al27 was removed in a 
sensitivity analysis as the population were all in a vegeta-
tive or minimally conscious state with the lowest possible 
Functional Independence Measure (FIM) score of 18. 
This resulted in a larger overall SMD 0.89, (95% CI: 
0.56 to 1.22, p<0.001), I2=0.00 (online supplemental 
figure 1). In an analysis with the three observational 
studies20 32 33 using FIM as their outcome, rehabilitation 
interventions showed an improvement in total FIM, 
overall MD of 28.24 points (95% CI: 16.33 to 40.15, 
p<0.001), I2=0.00%, between admission and discharge 
(figure 6).
Figure 3 Forest plots for outpatient/community- based rehabilitation for cardiac arrest survivors compared with standard 
intervention, effect on health- related quality of life as measured by SF-12 or SF-36 (Short Form Health Survey) at 12 months 
follow- up. (A) Physical Component Score, (B) Mental Component Score
 on S
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Neurological function data not included in meta-analysis
One observational study34 showed no significant change 
in neurological function after a community- based reha-
bilitation intervention for acquired brain injury. Further, 
Howell et al27 found by discharge, 6.2% of CA survivors 
with acquired brain injury in a vegetative or minimally 
conscious state achieved a good neurological functional 
outcome (defined as Glasgow Outcome Scale category 
4–5). Cognition, specifically executive function, is the 
primary outcome in one ongoing trial,36 with results due 
in 2024.
Survival
Survival was used as an outcome in one RCT.21 The 
study found no statistically significant reduction in risk 
of all- cause mortality (62% risk reduction, p=0.13, CI not 
stated). However, a statistically significant decrease in risk 
of cardiovascular death was found in favour of those who 
were allocated to the rehabilitation intervention (86% 
risk reduction, HR=0.14; p=0.03, CI not stated) one death 
in the intervention group due to stroke, six out of seven 
deaths in control group due to CA.
Rehospitalisation
No study reported on rehospitalisation.
Safety (serious and non-serious adverse events)
Reported in two observational studies24 28 involving 
exercise- based rehabilitation. No serious or non- serious 
events were reported in either study.24 28
Psychological well-being
Psychological well- being was reported in one RCT31 and 
three observational studies.24 25 34 No meta- analysis was 
Figure 4 Forest plots for outpatient/community- based rehabilitation for cardiac arrest survivors, effect on health- related 
quality of life (HRQoL) as measured by SF-12 or SF-36 (Short Form Health Survey) between baseline and 6 months follow- up (A) 
Physical Component Score, (B) Mental Component Score.
Figure 5 Forest plot for effect of inpatient rehabilitation on neurological function (NF) between admission and discharge.
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possible due to clinical heterogeneity between studies. All 
studies used self- reported symptom measurements and 
not a medical diagnosis of psychological well- being.
The RCT31 found that education- based rehabilitation 
had a positive effect on total anxiety and depression 
(p=0.002) and anxiety subscale (p<0.001) compared with 
standard care at 1- year follow- up.
An observational study25 found that an education/
psychological support- based intervention had a reduc-
tion in anxiety (32.10 points (SD 11.03) to 28.57 (SD 
9.65)) and depression (5.46 points (SD 4.37) to 3.7 (SD 
3.89)) between baseline and 3 months. This was main-
tained at 12 months follow- up (28.87 (SD 10.62) and 
3.36 (SD 4.29), respectively). An exercise- based reha-
bilitation intervention observational study24 found a 
non- significant reduction in anxiety (31.56 (SD 11.83) 
to 28.22 (SD 9.68), p=0.06) and depression (11.00 
(SD 13.08) to 9.22 (SD 11.88), p=0.46) from baseline 
to 8 weeks follow- up . An observational study involving 
a community- based rehabilitation intervention for 
acquired brain injury showed no statistically signifi-
cant change in anxiety or depression from baseline to 
2 months follow- up.34
Fatigue
One observational study29 found between baseline 
and study end (3–5 weeks) of an energy conservation 
and problem solving therapy intervention, a signifi-
cant decrease in self- reported total (p<0.001), physical 
(p=0.001) and cognitive (p=0.006) fatigue, with small 
to moderate effect sizes (r=0.23–0.25). Fatigue is the 
primary outcome in one ongoing trial,35 with results 
due in 2021.
Exercise and physical capacity
Reported in two observational studies.24 28 Meta- analysis of 
the two studies found that an 8- week exercise- based reha-
bilitation intervention significantly increased exercise 
duration (MD 3.72 min (95% CI: 0.49 to 6.95, p=0.02), 
I2=42.61% but not exercise capacity, overall SMD 0.41, 
(95% CI: −0.23–1.04, p=0.32), I2=0.00% (online supple-
mental figures 2 and 3).
Daily activity was reported in one observational study.28 
Measured by RT3 accelerometer, it increased after an 
8- week exercise- based rehabilitation intervention and 
continued to increase at 6- month follow- up (baseline 
143.02 vector magnitude/minute (vm/min) (SD 41.44), 
8 weeks 230.0 vm/min (SD 121.78), 6 months 289.89 vm/
min (SD 8.99), p=0.17).
Risk of bias and quality of evidence across studies
Quality of evidence (GRADE) for both the primary and 
main secondary outcomes, HRQoL and neurological 
function, was assessed as low for the RCTs and very low 
for the observational studies. Reasons for downgrading of 
evidence are described in the Summary of findings tables 
(online supplemental tables 3 and 4).
Heterogeneity between studies
Possibility for meta- analyses in this study was limited due 
to the heterogeneity in CA survivors populations, rehabil-
itation interventions and outcomes (online supplemental 
table 1).
Additional analyses
A priori, we planned several univariate meta- regression 
analyses,37 subgroups analyses and investigation of small 
study bias (see protocol, online supplemental file 1). 
However, due to the limited number of included studies, 
all of these analyses were not conducted, as recommended 
in the Cochrane Handbook for Systematic Reviews of 
Interventions.37
DISCUSSION
This study systematically investigated the effectiveness 
of rehabilitation interventions for CA survivors. Overall, 
quality of the body of evidence of these interventions is 
low or very low. Eleven of the 14 studies were observa-
tional and cannot determine the cause and effect of an 
intervention, but can only show the associated change 
in outcomes between one time point and another. The 
overall risk of bias of the three included RCTs ranged 
from ‘some concerns’ to ‘high risk of bias’ (figure 2A). 
Figure 6 Forest plot for effect of inpatient rehabilitation for cardiac arrest survivors with acquired brain injury on neurological 
function (NF) between admission and discharge as measured by the Functional Independence Measure (scale: 18–126 points, 
with higher scores indicating better function).
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Analysis of these RCTs showed no significant effect on 
HRQoL or neurological function with one RCT showing 
a positive effect on anxiety and depression (psycholog-
ical well- being). The included observational studies 
suggested some associated positive change in outcomes, 
but the quality of the body of evidence was generally low 
(figure 2B) with the majority having small or very small 
sample sizes and insufficient description of the content of 
the rehabilitation interventions. Hence, all of the findings 
should be interpreted with caution as additional evidence 
is needed and could substantially impact the interpreta-
tion of the results.
The meta- analysis of RCTs found no significant effect 
for rehabilitation interventions on HRQoL. However, it 
should be noted that only two RCTs22 23 31 were included 
in this pooled analysis. The RCT by Moulaert et al,31 
taken on its own, reported a significant effect on HRQoL 
compared with control in three out of eight SF-36 
domains (online supplemental table 1). Our findings on 
HRQoL, being mindful of the low number of included 
RCTs, are largely in agreement with an earlier systematic 
review of similar education- based rehabilitation interven-
tions for patients with coronary heart disease.15 While the 
review authors found some evidence for greater HRQoL 
in some domain scores, overall, they found no definite 
evidence for better HRQoL after education in compar-
ison to control.
A meta- analysis of two observational studies25 30 showed 
a significant associated increase in physical HRQoL. 
However, as is inherent to the study design, neither of 
the studies had a control group. From the control arms 
in the two RCTs,22 23 31 we see that CA survivors receiving 
standard care also seem to improve over time (mean 12.8 
points improvement in physical HRQol, online supple-
mental table 3). Thus, demonstrating the importance 
of using control group trial designs to determine the 
real effectiveness of rehabilitation interventions in this 
population.
Our main secondary outcome was neurological func-
tion. The only RCT31 to report neurological function 
found no effect of an outpatient intervention compared 
with usual care on cognitive function, however, Moulaert 
et al31 state that this was expected as the intervention 
did not include cognitive training. In the observational 
studies, inpatient rehabilitation was associated with 
improvements in neurological function for CA survi-
vors with acquired brain injury (figure 5). Three of the 
studies20 32 33 reported total FIM (figure 6). The total FIM 
minimal clinically important difference (MCID) has not 
been described for CA survivors, but in patients who had 
a stroke, the MCID has been shown to be an improvement 
of ≥22 points.38 Hence, the pooled mean improvement of 
28.24 points found in this study would indicate inpatient 
rehabilitation provides a clinically significant improve-
ment in neurological function for CA survivors. However, 
none of the studies had control arms, and all had several 
high risk of bias domains including insufficient descrip-
tion of intervention or small sample sizes. This review 
found very few studies aimed at improving neurological 
function including cognition for CA survivors. However, 
one ongoing RCT was found investigating a computer- 
based intervention to improve executive function with 
results due in 2024.36
Survival was only reported in one study21 that was judged 
to be of high risk of bias with missing data, therefore, no 
conclusions on the effect of rehabilitation on survival 
can be made. By definition, rehabilitation helps people 
to achieve and maintain optimum functioning in interac-
tion with their environments.7 Hence, survival would not 
seem to be a primary outcome for rehabilitation for CA 
survivors.
Two small observational studies24 28 reported exercise- 
based rehabilitation interventions as safe for CA survi-
vors. The reporting of no serious or non- serious events is 
in agreement with earlier studies exploring safety during 
moderate or high intensity exercise training for people 
with cardiovascular disease39–41 or implantable cardio-
verter defibrillators.42 However, both included studies 
had very small populations (8 and 10 participants) and 
much larger study populations are needed to establish 
the safety of exercise for CA survivors.
Psychological interventions have been shown to reduce 
anxiety and depression in patients with coronary heart 
disease.43 The RCT by Moulaert et al31 found a reduction 
in total anxiety and depression although their interven-
tion provided primarily education and screening for 
cognitive/emotional problems rather than psychological 
focused interventions. Education on the consequences 
of CA along with insight into their cognitive/emotional 
problems may have led to the participants’ improved 
psychological state. Alternatively, participants in the inter-
vention group could be referred for additional specialist 
support. However, we do not know what proportion of 
participants received additional specialist psychological 
support or how this may have influenced the results.
This is the first systematic review and meta- analysis to 
assess the effectiveness of rehabilitation interventions for 
CA survivors. Its strengths lie in the comprehensive liter-
ature searches, inclusion of both RCTs and observational 
studies, and the included wide range of outcomes rele-
vant to CA survivors. Nevertheless, there are a number of 
limitations. In order to pool the HRQoL data, the SF-36 
scores from two studies30 31 were transformed from sub- 
scales to component scores. Some overlap in physical/
mental domains between the eight subscales has been 
noted when using this transformation method.18 There-
fore, transformed scores may not completely represent 
the original study results.18 We included two studies with 
populations of CA survivors and people with anoxic brain 
injury due to other causes (45%34 and 42%32 participants 
with anoxic brain injury other causes) where CA survi-
vors subgroup data were not available. Including non- CA 
survivors may have influenced the results, however, we 
deemed the inclusion of these studies as important 
considering the paucity of data available. The effect of 
including studies with mixed populations on this review’s 
 on S
eptem









pen: first published as 10.1136/bm






9Joshi VL, et al. BMJ Open 2021;11:e047251. doi:10.1136/bmjopen-2020-047251
Open access
results is difficult to determine without greater examina-
tion of the aetiology and secondary consequences of the 
other non- CA causes of anoxic brain injury. However, 
Schmidt et al32 showed a similar change in FIM to two of 
the studies20 33 that only included CA survivors (figure 6).
Our primary outcome, HRQoL, is an important 
outcome in rehabilitation research.7 However, the choice 
of generic or disease- specific HRQoL measures may influ-
ence the results as generic measures of HRQoL can be 
crude with important details lost and large sample sizes 
required to demonstrate effect.4 44 45 In this review, all 
studies except one34 used generic measures of HRQoL.
Another element that potentially influenced our find-
ings may be the standard care received by the RCT control 
groups. Two21–23 of the included RCTs provided educa-
tional elements to both the intervention and control 
groups and in a third46 participants could have received 
cardiac rehabilitation.
The high heterogeneity found between studies, limiting 
meta- analysis, may be explained by the wide range of phys-
ical, neurological and psychological problems suffered 
by CA survivors.1 3–6 Most CA survivors will have a new or 
ongoing cardiac condition,1 and therefore, be eligible 
for cardiac rehabilitation.47 Neurological rehabilitation 
has been recommended to meet the ‘brain’ aspect of 
CA recovery.3 48 This can be mild cognitive impairments 
in self- caring CA survivors49 or more severe brain injury 
needing long- term residential care.3 Hence, different CA 
survivor populations lead naturally to the selection of 
different rehabilitation interventions and study outcomes.
Implications for future research and clinical practice
The majority of studies found by this systematic review 
were observational. Given their potential risk of bias and 
no control group, we recommend no further observa-
tional studies focusing on the question of effectiveness 
are conducted but instead there is a need for high- quality 
RCTs comparing rehabilitation interventions for CA 
survivors to standard care alone. Considering the small 
population of CA survivors, multicentre RCTs should be 
considered to achieve a sufficient sample size to deter-
mine an effect on specific outcomes. In view of the wide 
range of potential consequences after CA, future studies 
might also consider investigating interventions that 
target a single consequence of CA, for example, fatigue, 
or whether interventions should be multicomponent. 
A minimum outcome set for these future rehabilitation 
RCTs should include those recommended by COSCA 
(Core Outcome Set for Cardiac Arrest),4 HRQoL and 
neurological function, and consider including disease- 
specific outcomes. However, more research is needed 
to identify outcomes and measurement tools that reflect 
the range of rehabilitation needs of CA survivors. Agree-
ment on a CA survivors’ rehabilitation core outcome set 
would facilitate subsequent meta- analysis of study results 
providing a stronger body of evidence on rehabilitation 
after CA. Further, it is essential future RCTs use agreed 
reporting guidelines such as CONSORT (Consolidated 
Standards of Reporting Trials)50 or TIDieR (Template for 
Intervention Description and Replication)51 to detail the 
complex rehabilitation interventions under investigation. 
This systematic review has focused primarily on impair-
ment and function outcomes and less on activity and 
participation. Hence, future systematic reviews on this 
subject could consider including these outcomes.
Based on the low quality of the body of evidence, clinical 
rehabilitation guidelines should continue to be consensus 
based.1 10 11 In clinical practice, rehabilitation interven-
tions should be offered based on these consensus- based 
recommendations with ongoing monitoring of clinical 
outcomes. The documented secondary physical, neuro-
logical and psychological consequences of CA for survi-
vors are so comprehensive1 3–6 that we as clinicians must 
meet these needs in current clinical practice.
CONCLUSIONS
Given the overall low quality of evidence, this review 
cannot determine the effectiveness of rehabilitation 
interventions for CA survivors on HRQoL, neurological 
function or other included outcomes, and recommend 
further high- quality studies are conducted. In the interim, 
existing clinical guidelines on rehabilitation provision 
after CA should be followed to meet the high burden of 
secondary consequences suffered by CA survivors.
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The following electronic databases will be searched: MEDLINE, EMBASE, CINAHL, PsycINFO, AMED, The 
Cochrane Library (Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled 
trials (CENTRAL) and Web of Science (up to April 2021 without any restriction in publication date or 
language). 
Trial registries ISRCTN and the WHO ICTRP search portal, and the database ClinicalTrials.gov will be used 
to search ongoing trials relevant to the review, identify unpublished work, and describe upcoming 
publications within the studied area. The Cochrane Database of Systematic Reviews will be searched to 
identify former reviews that identify possible studies for inclusion. These will be screened for eligibility in the 
same manner as all other studies identified during the database searches.  
The search matrix will consist of a combination of relevant indexed terms (e.g. MeSH, Subject Headings or 
Thesaurus terms), keywords and synonyms for: 1) cardiac arrest, and 2) non-pharmacological rehabilitation 
interventions.  
Title and abstracts from the following conferences will be hand searched: ‘European Resuscitation Council 
Congress’, ‘American Heart Association’ and American College of Cardiology (all from 2009), and the ‘Post -
cardiac arrest conference’ (from 2013). 
To identify studies that were not captured by the search matrix, forward and backward citation searching will 
be conducted on all papers included after full-text screening by two authors (VLJ and MA). Backward 
citation searching involves screening the references in papers identified after full-text screening. Forward 
citation searching, searches papers that have cited any papers found after full test screening. References 
will be hand-searched and citations will be searched for via Web of Science. Titles will be screened for 
eligibility. Abstracts of possible eligible studies will be screened for eligibility as per all other studies 
identified during the original database searches. 
The first and last authors of unobtainable studies or studies with missing data will be contacted. 
  
Types of study to be included 
Included: 
- Randomised controlled trials using individual, cluster or any design including parallel group, cross 
overallocation trials, including pilot studies. - Non-randomised controlled trials 
- Prospective and retrospective observational studies with or without a control group. 
Excluded: 
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- Case reports 
  
Condition or domain being studied 
The number of people surviving a cardiac arrest is increasing due to improvements in bystander 
resuscitation and acute hospital care. However, following a cardiac arrest up to half of survivors experience 
cognitive, psychological and physical problems. These secondary problems plus the underlying cardiac 
condition present in the majority of cardiac arrest survivors may impact on survivors’ well-being and 
healthrelated quality of life. Non-pharmacological rehabilitation interventions have been recommended in 
international guidelines but the effect of these interventions remains unknown. A recent investigation into the 
outcomes for testing effectiveness of interventions for cardiac arrest survivors, by the COSCA initiative (core 
outcome set for cardiac arrest), recommended three measures be used: survival at 30 days or hospital 
discharge, neurological function and health-related quality of life (1).  
For reference list, see additional information section. 
  
Participants/population 
Studies investigating adults, over the age of 18, of both sexes, and all ethnicities who have survived a 
cardiac arrest will be eligible for inclusion. 
Studies that include both survivors of cardiac arrest, and people with cardiac disease without cardiac arrest 
will be managed in the following way; all trials that present data for cardiac arrest survivors in a subgroup 
will be included. Where data is not presented in a sub-group, we will contact trial authors to ascertain 
separate data on the survivors of cardiac arrest. If it is not possible to ascertain subgroup data and only 
pooled data is available, the study will only be included if at least 50% of participants were survivors of a 
cardiac arrest.  
  
Intervention(s), exposure(s) 
Studies investigating any non-pharmacological rehabilitation intervention for survivors of cardiac arrest, will 
be considered eligible for inclusion. Non-pharmacological interventions refers to interventions that are not 
primarily surgically or pharmacologically based or do not involve invasive technology. There will be no 
restrictions related to length of intervention, timing of intervention or timing of follow-up. The intervention 
may be a single session or a series of sessions. It may be provided one-to-one or in a group of survivors. 
Most cardiac arrest survivors have an underlying cardiac condition and hence cardiac rehabilitation 
intervention studies that include cardiac arrest survivors will be considered as a non-pharmacological 
intervention and included in this review. The cardiac rehabilitation may be exercise-based, psychological-
based, education based or comprehensive in nature. 
Exclusion criteria: 
1. All studies reporting on effectiveness of medical, surgical or invasive technology interventions will be 
excluded. 
2. Interventions in the emergency room or critical care unit will be excluded. 
3. Studies that do not report results at baseline and at minimum one follow-up point after intervention. 
  
Comparator(s)/control 
Comparator can include no treatment, active control, usual care, or where the intervention is in addition to 




The intervention may take place in any setting: in the hospital (but not while in the emergency room/critical 
care unit), outside the hospital, at survivors’ home or may start in hospital and cont inue following discharge 
from hospital or via telemedicine. 
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The outcomes are based on the those recommended by the COSCA initiative (1). The primary outcome will 
be health-related quality of life. Measures of health-related quality of life outcomes will include generic or 
disease-specific patient reported outcome measures. The outcome measure can be a single-item tool (e.g. 
‘How would you rate your overall quality of life?’) or a multi item tool (examples include 36-item Short Form 
Health survey and EuroQoL five dimensions questionnaire). For multi component/dimensional outcome 
measures a subscale which contains health-related quality of life will be favoured over the overall score of 
the measurement even if the overall score reflects health-related quality of life. 
Main secondary outcome: neurological function. Measures of neurological function measure the level of 
disability after a neurological event. Included measures may primarily test cognitive ability (for example the 
Mini-mental state examination) or may combine cognitive and physical ability hence measuring global 
disability (for example the Modified Rankin Scale). Measures may be clinician reported (for example the 
Cerebral Performance Category or Glasgow Outcome Scale –Extended) or observer reported (for example 
the Informant Questionnaire on Cognitive Decline in the Elderly, completed by relatives or carers) or patient 
reported (for example Two-simple questions). 
Measures of effect 
It has been suggested that outcomes for cardiac arrest survivors evolve over time and survivors should be 
reassessed at 30-days, 60-days and one-year after arrest (1, 2). Hence, data will be extracted at all time 
points that are the nearest possible to the recommended follow-up points (1) (survival at 30 days or hospital 




1. Survival at 30 days or hospital discharge (if both are reported, survival at 30 days will be favoured over 
survival at hospital discharge), and one year. Mortality due to any cause, but if proportion due to cardiac 
cause is available this will be reported. 
2. Re-hospitalization (all cause and the proportion due to cardiac cause if available) 
3. Serious adverse events: defined as resulting in death or re-hospitalization causing significant disability 
,including cardiovascular complications such as cardiac arrest or any arrhythmia with hemodynamic 
compromise.  
4. Non-serious adverse events for example musculoskeletal injury, palpitations, or dizziness.  
5. Psychological well-being: measured by patient reported symptoms of anxiety, depression, post-traumatic 
stress disorder or stress. The outcome measure can be a single-item tool (for example ‘How would you rate 
your overall psychological well-being?’) or a multi item tool (for example the Hospital Anxiety and 
Depression Scale).  
6. Fatigue outcomes: measured by patient reported outcomes such as the Fatigue impact scale. Measures  
may be disease specific or generic and multi-component/dimensional. For multi component/dimensional 
outcome measures a sub-scale which contains fatigue will be favoured over the overall score of the 
measurement even if the overall score reflects fatigue. 
7. Exercise capacity: measured by aerobic fitness. This will include any objective measure of the ability of the 
heart and lungs to get oxygen to the muscles where it can be consumed. This could be maximal or peak 
oxygen consumption. A change of the aerobic fitness could be an increase in peak oxygen consumption 
(VO2peak) obtained from a maximal cardiopulmonary exercise test or as a decrease in sub-maximal oxygen 
uptake at a given work load, or a decrease of sub-maximal heart rate at a given work load. 
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8. Physical capacity: measured by self-reported questionnaires, single item questions or objectives measures 
for example activity monitors or step counters. 
  
Data extraction (selection and coding) 
Selection of studies will be done by merging all search results into the technology platform, Covidence. 
Duplicates will be removed before two authors (VLJ and MA) will independently screen titles and abstracts 
followed by full-text screening of potentially eligible studies. Any disagreements will be discussed and 
resolved with a third review author (JC). For randomised controlled crossover trials data will be handled as it 
would have been a randomised controlled trial and therefore data will be extracted for baseline and from the 
assessment of effect from the first period (data from after the cross-over will not be extracted). 
A standardised pre-piloted form will be used to extract data from all the included studies. 
The following data will be extracted if it is relevant in terms of study design (observational vs randomised 
controlled studies) by two independent reviewers (VLJ & MA):  
1. Source of study and author contact details 
2. Study design, study duration, setting and country. 
3. Participant characteristics: age, sex, cause of cardiac arrest, place of cardiac arrest, cardiac arrest  
circumstances, health-status of participants including details of any ongoing cardiac condition (for example 
myocardial infarction), in hospital interventions and whether they received targeted temperature 
management and/or an implantable cardioverter defibrillator. 
4. Number of groups and number of participants in each study, and study arm. 
5. Description and components of rehabilitation intervention and any control, length of intervention, dose and 
frequency. 
6. Theory or mechanism of the study intervention. 
7. Which primary and secondary outcomes as defined above are present and time points of outcomes.  
8. For each outcome of interest: sample size, estimate of effect and confidence interval; p value and subgroup 
analyses. 
9. Information for assessment of risk of bias. 
Any discrepancies in data extraction will be investigated and discussed, then if necessary resolved with a 
third review author (JC). 
  
Risk of bias (quality) assessment 
Two review authors (VLJ & MA) will independently assess the risk of bias in included studies. RoB 2.0 tool 
for randomised controlled trials ROBINS-I (risk of bias in non-randomised Studies – of Interventions) will be 
used to assess risk of bias in observational studies.  
Risk of bias will be assessed for each outcome within each study. While some items are generic across 
outcomes, where potential differences may occur (for example between subjective and objective measures), 
outcomes will be assessed separately and may be judged at a different level of bias within the same study. 
Any disagreements between review authors will be discussed and resolved with a third review author (JC).  
  
Strategy for data synthesis 
Results from the different study designs will be presented and pooled separately.  
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We will undertake a meta-analysis where two or more trials are similar enough clinically and statistically for 
pooling of trials to be appropriate. Where there is high heterogeneity between studies or inappropriate 
quantitative reporting of outcomes, a narrative synthesis of outcomes from included studies will be provided.  
If it is possible to conduct a meta-analysis a random effects meta-analysis will be used given the likely 
presence of some clinical heterogeneity across studies. Continuous data will be expressed as the mean 
difference (MD) or standardized mean difference (SMD) and their respective confidence intervals (CI) will be 
calculated. 
For dichotomous outcomes (serious and non-serious adverse events) and for outcomes of observational 
studies relative risk ratios (RR) along with a CI will be calculated using random effects meta-analysis.  
For time to even outcome (survival, re-hospitalization) hazard ratios will be pooled if presented. 
Statistical heterogeneity of the study results will be examined using Cochran Q test and quantified with I² 
values and the between study variance I². Qualitative assessment of heterogeneity will be assessed by 
comparing the characteristics of included studies. Assessment of small study bias will be assessed by 
calculating an Egger's test score and illustrated with a funnel plot. If small study bias is present defined by a 
positive Egger's test, a metatrim analysis will be conducted.  
If the included studies need network meta-analysis to be pooled this will be performed, as described in 
chapter 16.6.3 of the Cochrane Handbook. 
The confidence in estimates of the effects of interventions will be assessed using the Grading of 
Recommendation, Assessment, Development and Evaluation system (GRADE). 
The paper will be reported according to the Preferred Reporting Items for Systematic Reviews and 
MetaAnalyses (PRISMA) guidelines. 
  
Analysis of subgroups or subsets 
If possible, we will carry out the following subgroup and strat ified analyses to explore heterogeneity of the 
studies. Location of cardiac arrest (in versus out-of-hospital). 
1. Mode of delivery of intervention (supervised vs non-supervised). 
2. Provision of intervention (individual vs group based). 
3. Content of rehabilitation, single component (for example: exercise-based/education-based/psychological 
based) vs comprehensive. 
4. Received an implantable cardioverter defibrillator vs did not receive an implantable cardioverter defibrillator. 
5. Random sequence generation (low/some concerns/high); random sequence concealment (low/some 
concerns/high).  
6. Overall risk of bias (low/some concerns/high). 
7. Length of intervention (single session vs 1-6-weeks vs over 6-weeks) 8. Duration of trial follow-up (1-12 
weeks vs 13-24 weeks vs over 24 weeks). 
9. Setting of trials (single vs multicentre). 
10. Continent of publication. 
11. Self-reported cognitive ability vs self-reported cognitive and physical ability. 
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12. Clinician reported cognitive ability vs observer reported vs self-reported. 
Meta-regression will be carried out to investigate the effect of continuous variables including age, sex 
distribution and all sub-group analyses listed above. 
  




Organisational affiliation of the review 
Danish Knowledge Centre for Rehabilitation and Palliative Care 
http://www.rehpa.dk/ 
  
Review team members and their organisational affiliations 
Mrs Vicky Joshi. Danish Knowledge Centre for Rehabilitation and Palliative Care 
Dr Jan Christensen. Danish Knowledge Centre for Rehabilitation and Palliative Care 
Mr Esben Lejsgaard. Danish Knowledge Centre for Rehabilitation and Palliative Care 
Professor Ann-Dorthe Zwisler. Danish Knowledge Centre for Rehabilitation and Palliative Care 
Professor Rod Taylor. Institute of Health Research, University of Exeter Medical School; Danish Knowledge 
Centre for Rehabilitation and Palliative Care 
Professor Jørgen Feldbæk Nielsen. Aarhus University, Hammel Neurocenter Denmark 
Dr Lars Tang. Danish Knowledge Centre for Rehabilitation and Palliative Care 
  
Type and method of review 
Intervention, Meta-analysis, Systematic review 
  
Anticipated or actual start date 
01 November 2018 
  
Anticipated completion date 
31 July 2021 
  
Funding sources/sponsors 
Funding for the writing of the review protocol, data analysis and preparation of the article for publication will 
be provided by REHPA - Danish Knowledge Centre for Rehabilitation and Palliative Care, University of 
Southern Denmark. 
  








Stage of review 
Review Ongoing 
  
Subject index terms status 
Subject indexing assigned by CRD 
  
Subject index terms 
Heart Arrest; Humans; Medicine; Survivors 
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Date of registration in PROSPERO 
11 October 2018 
  
Date of first submission 
19 September 2018 
  
Stage of review at time of this submission 
  
Stage  Started Completed 
Preliminary searches Yes Yes 
Piloting of the study selection process Yes Yes 
Formal screening of search results against eligibility criteria  Yes Yes 
Data extraction Yes Yes 
Risk of bias (quality) assessment Yes Yes 
Data analysis Yes Yes 
 
The record owner confirms that the information they have supplied for this submission is accurate and 
complete and they understand that deliberate provision of inaccurate information or omission of data may be 
construed as scientific misconduct. 
The record owner confirms that they will update the status of the review when it is completed and will add 
publication details in due course. 
  
Versions 
11 October 2018 
07 May 2021 
12 May 2021 
15 May 2021 
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Power ed by TCPDF ( www.tcpdf .org) 
 




heart arrest [MeSH Terms] rehabilitation [MeSH Terms] 
out-of-hospital cardiac arrest [MeSH Terms] physical medicine [MeSH Terms] 
 rehabilitation nursing [MeSH Terms] 
heart arrest [Title/Abstract] exercise [MeSH Terms] 
heart arrests [Title/Abstract] social support [MeSH Terms] 
cardiac arrest [Title/Abstract] psychological adaptation [MeSH Terms] 
cardiac arrests [Title/Abstract] cognitive behavior therapy [MeSH Terms] 
cardiopulmonary arrest [Title/Abstract] health education [MeSH Terms] 
 aftercare [MeSH Terms] 
 rehabilitation, vocational [MeSH Terms] 
  
 rehabilitation [Title/Abstract] 
 vocational [Title/Abstract] 
 aftercare [Title/Abstract] 
 telerehabilitation [Title/Abstract] 
 physical medicine [Title/Abstract] 
 exercise [Title/Abstract] 
 exercises [Title/Abstract] 
 physical activity [Title/Abstract] 
 social support [Title/Abstract] 
 psychological adaptation [Title/Abstract]) 
 coping behavior [Title/Abstract]) 
 coping skills [Title/Abstract]) 
 adaptive behavior [Title/Abstract]) 
 cognitive behavior therapy [Title/Abstract] 
 cognitive behavioral therapy [Title/Abstract] 
 cognitive behavior therapies  [Title/Abstract] 
 cognitive behavioral therapies [Title/Abstract] 
 cognitive psychotherapy [Title/Abstract] 
 cognitive psychotherapies [Title/Abstract] 
 acceptance and commitment therapy [Title/Abstract] 
 mindfulness [Title/Abstract] 
 health education [Title/Abstract]) 
  
  
AMED 1985 to date 
POPULATION INTERVENTION 






(MH "Physical Medicine") 
(MH “Rehabilitation nursing”) 
(MH Exercise+) 
(MH Support, Psychosocial+) 
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(MH Adaptation, Psychological+) 
(MH Cognitive therapy+) 
(MH Health education+) 
(MH After Care) 
 
















cognitive behavio#r therap* 
cognitive behavio#ral therap* 
cognitive behavioral therap* 
cognitive psychotherap* 

























(MH "Physical Medicine") 
(MH “Rehabilitation nursing”) 
(MH Exercise+) 
(MH Support, Psychosocial+) 
(MH Adaptation, Psychological+) 
(MH Cognitive therapy+) 
(MH Health education+) 
(MH After Care) 
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cognitive behavio#r therap* 
cognitive behavio#ral therap* 
cognitive behavioral therap* 
cognitive psychotherap* 




Embase 1974 to present 
heart arrest Exp 











































cognitive behavio#r therap* 
cognitive behavio#ral therap* 
cognitive behavioral therap* 
cognitive psychotherap* 
acceptance and commitment therapy 
mindfulness 
health education 
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PsychINFO 1806 to present 





























cognitive behavio#r therap* 
cognitive behavio#ral therap* 
cognitive behavioral therap* 
cognitive psychotherap* 












Search string: (TS=Topic) 
 
TS=(rehabilitation) OR TS=(vocational) OR 
TS=(aftercare) OR TS=(telerehabilitation) OR 
TS=("physical medicine") OR TS=(exercise) OR 
TS=(exercises) OR TS=("physical activity") OR TS=("social 
support") OR TS=("psychological adaptation") OR 
TS=("coping behavio*") OR TS=("coping skills") OR 















cognitive behavio#r therap* 
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therap*") OR TS=("cognitive psychotherap*") OR 
TS=("acceptance and commitment therapy") OR 




TS=("heart arrest") OR TS=("cardiac arrest") OR 
TS=("heart arrests") OR TS=("cardiac arrests") OR 
TS=("cardiopulmonary arrest") OR 
TS=("cardiopulmonary arrests") 
 
cognitive behavio#ral therap* 
cognitive behavioral therap* 
cognitive psychotherap* 




The Cochrane library (SRs and CENTRAL) 
As for Medline but using CENTRAL’s  search builder 
syntax. 
 




World Health organisation International Clinical Trials Registry Platform (ICTRP) and ClinicalTrials.gov 
(Condition) Cardiac arrest 
 












cognitive behavio#r therap* 
cognitive behavio#ral therap* 
cognitive behavioral therap* 
cognitive psychotherap* 
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Sample search matrix: 
MEDLINE Search matrix: 
 
Search (((((((((((((((((((((((((((((((((rehabilitation[MeSH Terms]) OR physical medicine[MeSH Terms]) OR rehabilitation 
nursing[MeSH Terms]) OR exercise[MeSH Terms]) OR social support[MeSH Terms]) OR psychological adaptation[MeSH 
Terms]) OR cognitive behavior therapy[MeSH Terms]) OR health education[MeSH Terms]) OR aftercare[MeSH Terms]) 
OR rehabilitation, vocational[MeSH Terms]) OR rehabilitation[Title/Abstract]) OR vocational[Title/Abstract]) OR 
aftercare[Title/Abstract]) OR telerehabilitation[Title/Abstract]) OR physical medicine[Title/Abstract]) OR 
exercise[Title/Abstract]) OR exercises[Title/Abstract]) OR physical activity[Title/Abstract]) OR social 
support[Title/Abstract]) OR psychological adaptation[Title/Abstract]) OR coping behaviour[Title/Abstract]) OR coping 
skills[Title/Abstract]) OR adaptive behavior[Title/Abstract]) OR cognitive behavior therapy[Title/Abstract]) OR 
cognitive behavioral therapy[Title/Abstract]) OR cognitive behavior therapies[Title/Abstract]) OR cognitive behavioral 
therapies[Title/Abstract]) OR cognitive psychotherapy[Title/Abstract]) OR cognitive psychotherapies[Title/Abstract]) 
OR ((acceptance[Title/Abstract] AND commitment therapy[Title/Abstract]))) OR mindfulness[Title/Abstract]) OR 
health education[Title/Abstract])) AND (((((((heart arrest[MeSH Terms]) OR out of hospital cardiac arrest[MeSH 
Terms]) OR heart arrest[Title/Abstract]) OR heart arrests[Title/Abstract]) OR cardiac arrest[Title/Abstract]) OR cardiac 
arrests[Title/Abstract]) OR cardiopulmonary arrest[Title/Abstract]) 
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Supplementary data Table 2. Studies excluded at full text stage with reasons 
Excluded study Reason for exclusion 
Ada, 2018 Conference abstract 
Arabia, 2011 Mixed population of people who have suffered a major cardiac event 
Baston, 2017 Conference abstract 
Berg, 2020 Mixed population of ICDs implanted for primary and secondary prevention and 
authors did not have separate data on number of cardiac arrest survivors. 
Bermejo, 2015 Conference abstract 
Boyce, 2017 Outcome data only at baseline 
Chanu, 2016 Not survivor of cardiac arrest population 
Helmark, 2016  Conference abstract 
Choi, 2017 No survivor of cardiac arrest population 
Dougherty, 1997 Not an intervention study 
Dougherty, 2015 Mixed population of ICDs implanted for primary and secondary prevention and 
authors did not have separate data on number of cardiac arrest survivors.  
Exposito, 2012 Conference abstract 
Goldman, 2013 Conference abstract 
Harbinson, 2017 Not survivor of cardiac arrest population 
Irvine, 2011 Not survivor of cardiac arrest population 
Kim, 2017 Not effect study 
Ko, 2020 Not survivor of cardiac arrest population 
Konh, 2000 Not survivor of cardiac arrest population 
Markus, 2017 Not rehabilitation intervention 
Mochizuki 2014 Conference abstract 
Moroni, 2006 Not survivor of cardiac arrest population 
Moulaert, 2016 Economic evaluation 
Moulaert, 2011 Study rationale 
Moulaert, 2007 Study protocol 
Munjal, 2018 Conference abstract 
Sears, 2004 Systematic review 
Stock, 2019 Not survivor of cardiac arrest population 
Takahashi, 2015 Intervention in intensive care unit 
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Supplementary data Fig. 1. Forest plot for effect of inpatient rehabilitation for CA-survivors with acquired 
brain injury on neurological function (NF) between admission and discharge, sensitivity analysis with Howell 




Supplementary data Fig. 2. Forest plot for effect of exercise-based rehabilitation for CA-survivors on 
exercise duration (ED) (minutes) between baseline and 8 weeks follow-up. 
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Supplementary data Fig. 3. Forest plot for effect of exercise-based rehabilitation for CA-survivors on 
exercise capacity (EC) between baseline and 8 weeks follow-up. 
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Supplementary data Table 3. Summary of findings: HRQoL 
Rehabilitation for improving health related quality of life (HRQoL) in survivors of cardiac arrest 
 
Randomised controlled trials 








Physical component score 
difference between baseline 
and 12 months follow-up (0-
100 points, higher scores 
better) 









Mental component score 
difference between baseline 
and 12 months follow-up (0-
100, higher scores better) 




 108(2) ++oo 
Lowb 
 
Prospective observational studies 
HRQoL 
Physical component score 
difference between at 6 
months follow-up (0-100, 
higher scores better) 






in either trial 
HRQoL 
Mental component score at 6 
months follow-up (0-100, 
higher scores better) 






in either trial 
 
aGRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect. 
Moderate quality: Further research is l ikely to have an important impact on our confidence in the estimate of effect and 
may change the estimate. 
Low quality: Further research is very l ikely to have an important impact on our confidence in the estimate of effect and 
is l ikely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
Explanations 
bHigh risk of bias in one of the two studies (‘some concerns’ with criteria: deviations from intended outcomes and 
selection of the reported results, ‘high risk of bias’ with criteria: measurement of the outcome), some indirectness of 
evidence in one study (intervention aimed at people with new ICD implanted) and due to the serious imprecision in both 
studies (small number of participants). 
cHigh risk of bias in one study out of two studies, both studies were observational. 
dConsiderable heterogeneity (I2=90.17%) (point estimates and confidence intervals vary considerably). 
Key: CI: Confidence interval; HRQoL: Health related quality of l ife; SMD: Standardized mean difference 
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Supplementary data Table 4. Summary of findings: neurological function 
Effect of inpatient rehabilitation on neurological function for survivors of cardiac arrest with acquired brain injury 
 
All  observational studies 







Improvement in function 
between admission and 
discharge (Functional 
independence measure and 
Barthel index) 
- SMD 0.71 
effect size (CI 
0.45-0.96) 
 187(5) +ooo 
Very Lowd 
No comparison 




aGRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect. 
Moderate quality: Further research is l ikely to have an important impact on our confidence in the estimate of effect and 
may change the estimate. 
Low quality: Further research is very l ikely to have an important impact on our confidence in the estimate of effect and 
is l ikely to change the estimate. 
Very low quality: We are very uncertain about the estimate 
dHigh risk of bias in all studies (multiple domains) and all were observational studies. 
Key: CI: Confidence interval; SMD: Standardized mean difference 
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Supplementary data 2: Table 1. Characteristics of studies investigating rehabilitation interventions for survivors of cardiac arrest  















Number of included 
participants (N) 
Age (mean) 
Gender (male, %) 





Duration (time period and/or number of 
sessions) 
 



























Acquired brain injury due 









inpatient rehabilitation services. 
Admission period mean 69.8 days (SD 
59.4) 
FIM subscales activities of 
daily living, mobility, 




Total FIM improved from admission mean 
63.92 days (SD 32.82) to mean discharge 






































Three components: 1) physiologic 
relaxation, 2) Cognitive behavioral 
therapy and 3) Health education focusing 
on cardiac risk factors. Delivered by 
experienced nurses.  
Control received only the health 
education component. 
4 weeks, mean 11 sessions (30 minutes 
each) 
All-cause mortality; 
Risk of cardiovascular 
death; 
Non-Fatal cardiac effects 
2 years 
 
Reduction in risk of all-cause mortality for 
the intervention group was 62%, but this was 
not statistically significant, (p=0.13). Risk of 
cardiovascular death was significantly 
reduced in the intervention group by 86% 
compared to conventional treatment at two-
years follow-up (hazards ratio =0.14; p=0.03; 
one death in the intervention group due to 
stroke, six out of seven deaths in control 
group due cardiac arrest. Confidence 











of a telephone 
intervention by 
expert nurses after 
an ICD; 
Long-Term 














Cardiac arrest survivors 
with first time ICD 
implantation for secondary 
prevention of cardiac 
arrest 





















1) Booklet mailed to study participants on 
strategies to manage recovery, 2) 
structured information provided by 
experienced cardiovascular nurses to 
improve self-efficacy to deal with illness 
demands, and to reduce anxiety, through 
identification of illness related problems 
and behavioral strategies to manage them 
including role playing, problem-solving, 
goal-setting and collaborating on the 
learning assignment for the coming week. 
Usual care participants received 
treatment as usual from their health care 
providers and standardized hospital-
based education about the ICD in the 
form of a booklet, videotape, or both. 
SF-12 Physical + Mental 
component sub-scale 
(separate results for other 
outcomes reported in the 
paper were not available 
for CA-survivors) 
Baseline, 1, 3, 
6, 12 months 
Rehabilitation interventions showed no 
statistical effectiveness on either SF-12 
physical or mental subscales at any follow-up 
point compared to standard care. 
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b. First 8 weeks after hospital discharge and 
ICD implantation (15-20 minute calls, 













and heart rate 











Cardiac arrest survivors 
with first time ICD 
implantation for secondary 









Supervised aerobic exercise plus home 
walking 
3 days per week for total of 8 weeks (24 
sessions) + 1 hour of home walking twice 
a week. 
 
SF-12 Physical + Mental 
component sub-scale; 
State Trait Anxiety 
Inventory; 
Center for Epidemiological 
Studies–Depression Scale; 
Total exercise time 
(minutes); 
Oxygen pulse (VO2/HR); 






Quality of life (Short Form–12) showed a 
non-significant improvement in physical and 
mental sub-scale scores and non-significant 
reduction in anxiety and depression. 
 
Exercise duration, oxygen uptake at 
anaerobic threshold, and metabolic 
equivalents were improved after 8 weeks of 
exercise. 
 
There were no lethal cardiac arrhythmias 
experienced during exercise testing and no 
participants required cardioversion. There 
were no sustained ventricular arrhythmias 
during supervised exercise or home walking 
sessions in any of the study subjects. 
 
 
SF-12 physical health were sustained at 6 
months as well as an increase in daily activity 









partner trial: A 
randomized 
controlled trial of 2 
interventions to 
improve outcomes 










Cardiac arrest survivors 
with first time ICD 
implantation for secondary 


















Intervention consisted of 4 elements: 1) 
Information booklet with strategies for 
health recovery after ICD implant. 2) 
Nurse telephone support to improve self-
efficacy and problem solve. Components 
of this support were as per the 
intervention in Dougherty, 2004, 2005. 
3) Pager access to a study nurse 4) an 
informational video provided by the 
device company.  
10 telephone calls over 12 weeks 
SF-12 Physical + Mental 
component sub-scale; 




Baseline, 3, 6, 
12 months 
All outcomes improved between baseline 






























arrest survivors who 
suffered anoxic brain 
injury and required 













Daily multidisciplinary neurological 
rehabilitation. Speech therapists and 
psychologist were available for 
those needing their service. 
Admission period mean 84 days (SD 57) 
(minimum 15 sessions per week of 






Mean improvement in Barthel index 3.4 (SD 
4.4) 
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Cardiac arrest survivors, 
direct transfer from 
intensive care unit, all in 
coma, vegetative state or 







Daily neurorehabilitation  
Mean 84 days (SD 50) 
 
Glasgow outcome scale; 
FIM; 




Total FIM improved from mean (SD) 18 (0) to 
25 (19) points between admission and 
discharge. 
6.2% of patient achieved a good functional 
outcome defined as Glasgow Outcome Scale 
4-5.  
Coma remission scale improved from mean 
(SD) change of 9 (5) to 13 (7) points (scale 0-
























Cardiac arrest survivors 
who received successful 
percutaneous coronary 













Cardiac rehabilitation including aerobic 
exercise, advice on secondary risk factors, 
diet and lifestyle, advice on medication by 
a cardiologist. Exercise was continued at 
home at 60% intensity of the heart rate 
reserve. 
6 weeks (3x50-minute per week exercise 









Baseline + 8 
weeks 
Significant improvement in exercise capacity.   
 
No fatal cardiac complications, such as 
abnormal ECG, cardiac arrest, death or 
myocardial infarction observed. 









An intervention for 
cardiac arrest 
survivors with 












Cardiac arrest survivors at 
least 3 months post 











Energy Conservation and Problem Solving 
Therapy delivered by an occupational 
therapist. 
Up to 4 weeks (45 minute sessions twice a 
week) 
Modified Fatigue Impact 
Scale; 









Significant decreases on the Modified 
Fatigue Impact Scale total (p<0.001), 
subscales physical (p=0.001) and cognitive (p 
= 0.006) fatigue were observed with small to 
moderate effect sizes of r=0.23–0.25. 
Change effect sizes were small for the 
Fatigue Severity Scale (r=0.11), Patient 
Reported Outcomes Measurement 
































Cardiac arrest survivors 



















Inpatient information provided via 
leaflets, bespoke video and direction to a 
social media website for cardiac arrest 
survivors and caregivers; telephone and 
clinic follow-up with ICU nurse, 
cardiologist and psychiatrist. If 
psychological issues were identified, 
patients and caregivers were offered 
further interventions. 
In-hospital + clinic follow-up at: 8-weeks, 
6-months and 12-months post-hospital 
discharge. 




Significant improvement in all domains of 










after cardiac arrest 






Survivors of cardiac arrest 
at least two weeks after 








Intervention for survivors of cardiac arrest 
and their caregivers provided by specialist 
nurses including 1. Screening for cognitive 
and emotional problems. 2. Provision of 
support and information on cardiac arrest 
SF-36 domain scores; 
EuroQol Visual Analogue 
Scale; 
Cognitive log 
Baseline, 3 + 
12 months 
At 12 months there were significant 
differences in estimated means in favour of 
the intervention group on three domains of 
quality of life on the SF-36: Role Emotional 
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At clinic or at 
home 
 





















and possible neurological consequences. 
3. Promotion of self-management 
strategies. 
4. Referral to specialized care if indicated.  
Control group received standard care with 
potential for referral to cardiac 
rehabilitation. 
1-6 individual sessions 
 
Adult Memory and 
Information processing 
battery task A; 
Verbal fluency; 
Trail making Test A; 
Trail making Test B; 
Paragraph recall direct; 
Paragraph recall delayed; 
Cognitive Failures 
Questionnaire; 
Hospital Anxiety and 
Depression Scale (anxiety 
and depression sub-scales 
and total); 
Impact of Event Scale 
(p=0.006), Mental Health (p=0.003) and 
General Health (p=0.010). 
 
No significant effectiveness on cognitive tests 
compared to standard care at any follow-up 
point. 
 
The intervention group scored significantly 
better on overall emotional state (anxiety 

























Patients admitted to a 
rehabilitation unit with 
cerebral anoxia (15 due to 








In-patient rehabilitation unit 
Admission period mean 59.5 days (SD 
41.4) 
 
FIM Admission + 
discharge 
Total FIM improved from admission mean 

























Survivors of cardiac arrest 









Mean 61.2 days (SD 68.4) 
 
FIM subscales activities of 
daily living, mobility, 
cognition and total 
Admission + 
discharge 
Total FIM improved from admission mean 

























Adults with cerebral 
anoxia in residential care 
(11 due to cardiac arrest, 9 










Psychotherapy, support group, physical 
activities and cultural and/or artistic 
activities. Participants could choose to be 
in all or some of the activities. 
2-months 
 
Glasgow outcome score 
extended; Bermont Vost 
Alexithymia questionnaire; 
Patient Competency 
Rating scale (agnosia); 
Quality of Life After Brain 
Injury questionnaire; 
Barrow Neurological 
Institute screen of higher 
cerebral functions; 
Hospital Anxiety and 
Depression scale 
Baseline, 2 + 
4 months 
Quality-of-life was significantly improved 
between baseline and intervention end at 
two months. 
No change found in neurological function or 
anxiety and depression. 
ICD: Implantable Cardioverter-Defibrillator; FIM: Functional Independence Measure; NS: Not stated; SF: Short form health survey  
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